Targeted intraoperative radiotherapy tumour bed boost during breast-conserving surgery after neoadjuvant chemotherapy

ConclusionIORT during lumpectomy after neoadjuvant chemotherapy as a tumour bed boost appears to give results that are not worse than external beam radiotherapy boost. These data give further support to the inclusion of such patients in the TARGIT-B (boost) randomised trial that is testing whether IORT boost is superior to EBRT boost.

http://link.springer.com/10.1007/s00066-016-1072-y

Source: Strahlentherapie und Onkologie - November 16, 2016 Category: Cancer & Oncology Source Type: research